Hence, we selected in-vivo model systems: the hamster model to demonstrate K76 downregulation during sequential progression of oral cancer, and the KO mice model to evaluate the effect of KRT76 loss. The gene discussed is KRT76; the disease is lip and oral cavity carcinoma.